InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
03/20/20 9:19 AM
profile icon
Pennyes Free
02/26/20 6:21 PM
profile icon
stockmama22 Free
03/27/19 2:40 PM
profile icon
Renee PremiumMember
03/25/19 4:49 PM
profile icon
Jerm17 Free
03/22/19 2:51 PM
profile icon
willlbone Free
03/22/19 11:02 AM
profile icon
CryptoDragon99 Terminated
03/19/19 9:43 PM
profile icon
Maso11 Free
01/05/19 9:59 AM
profile icon
Maso11 Free
01/04/19 3:45 PM
profile icon
Jerm17 Free
01/04/19 9:48 AM
profile icon
XenaLives PremiumMember
09/08/18 12:48 PM
profile icon
Upset Wookie Free
07/12/18 7:13 AM
profile icon
SanDiegoAlan Free
07/12/18 3:34 AM
profile icon
Upset Wookie Free
07/11/18 4:05 PM
profile icon
TheAnnointedOne Free
07/10/18 12:32 PM
profile icon
microcapbiotech Free
07/10/18 10:56 AM
profile icon
stockmama22 Free
07/10/18 9:47 AM
profile icon
ClayTrader Free
07/09/18 4:46 PM
profile icon
cjstocksup PremiumMember
07/09/18 4:09 PM
profile icon
Roadtojourney Free
07/09/18 2:50 PM
profile icon
Roadtojourney Free
07/09/18 2:49 PM
profile icon
UP Trend Free
07/09/18 2:02 PM
profile icon
TraderMeZz Free
07/09/18 12:16 PM
profile icon
cjstocksup PremiumMember
07/09/18 11:01 AM
profile icon
stockmama22 Free
07/09/18 10:47 AM
profile icon
davidsson10 Free
07/09/18 10:45 AM
profile icon
cjstocksup PremiumMember
07/09/18 9:57 AM
profile icon
ZLAZARUS Free
06/10/18 3:03 AM
profile icon
stockmama22 Free
01/30/18 7:05 PM
profile icon
INTL Free
01/26/18 11:49 AM
profile icon
CashCrisis Free
01/25/18 9:13 AM
profile icon
CansoSpaceMan Free
01/22/18 11:22 AM
profile icon
stockmama22 Free
01/11/18 10:28 AM
profile icon
Jacob76 Free
11/24/17 9:13 AM
profile icon
stockmama22 Free
11/22/17 5:48 PM
profile icon
ice1234 Free
10/24/17 3:08 PM
profile icon
ClayTrader Free
10/11/17 4:17 PM
profile icon
Joecanada13 Free
09/25/17 4:23 PM
profile icon
Joecanada13 Free
09/25/17 2:24 PM
profile icon
Joecanada13 Free
09/20/17 3:48 PM
profile icon
Joecanada13 Free
09/20/17 3:46 PM
profile icon
wiltonio Free
09/19/17 8:28 AM
profile icon
Joecanada13 Free
09/13/17 3:31 PM

MabVax Therapeutics Holdings Inc. (fka MBVXQ) RSS Feed

Followers
57
Posters
248
Posts (Today)
0
Posts (Total)
1194
Created
04/12/01
Type
Free
Moderators

www.mabvax.com

Ticker: MBVX
 

 

MabVax Therapeutics Holdings is a clinical-stage biopharmaceutical company focused on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. We generate our pipeline of antibody-based product candidates from patients who have been vaccinated with propriety vaccines licensed from Memorial Sloan-Kettering Cancer Center, or MSKCC. Our approach of surveying the protective immune response from many patients to identify the ideal monoclonal antibody candidate against a specific target on the surface of a cancer cell is a novel next-generation human antibody technology platform. Our approach to antibody discovery is to seek to identify the antibody candidates with superior performance characteristics while minimizing many of the toxicity and off target binding drawbacks of other discovery technologies. Our lead antibody candidates have been recovered from patients who had substantially better treatment outcomes than almost all other patients in clinical trials we conducted or that were conducted by our partners. Our therapeutic vaccines were developed at MSKCC and are exclusively licensed to us pursuant to agreements with MSKCC in 2008. These vaccines are administered in the adjuvant (period following conventional treatment consisting of watchful waiting) setting and have shown in clinical studies to elicit a protective antibody response. The antibodies are intended to seek out circulating tumor cells and micrometastases (small clusters of cancer cells) to kill them before they can cause cancer recurrence. Our lead cancer vaccines targeting recurrent sarcoma (soft tissue cancer) and ovarian cancer are currently in proof of concept Phase II multi-center clinical trials. Both trials have received substantial federal grant monies to support their development. A vaccine to address the orphan disease neuroblastoma (cancer starting in the adrenal gland of children which may spread to nervous tissue and bone marrow) has completed an initial Phase I trial at MSKCC and is expected be ready for a Phase II trial by early 2015. MSKCC and the Company have completed additional Phase I vaccine clinical trials in melanoma, ovarian cancer, and small cell lung cancer over the last three years.MBVX Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y
 
 
 
MBVX vs ETF alternatives
ETFs Today 3mths 1Yr YTD
<tr class="symRow selected" '="" nowrap=""> MBVX 2.65% 149.46% 61.90% 16.00%
IJR -0.75% 0.24% 9.06% 4.04%
EES -0.52% 1.71% 5.66% 2.96%
SCHA -0.62% 2.87% 10.13% 5.04%
VIOO -0.60% 0.58% 9.21% 3.77%
VB -0.59% 1.19% 9.77% 5.33%
DWAS -0.55% 1.83% 12.72% 6.64%
SAA -0.21% -49.24% -40.19% -47.12%
Most Recent MBVX Videos
No MBVX Videos…

My Stocks Activity For MBVX

Sassykoala avatar Sassykoala added MBVX
Added to MyStocks 48 days ago
kjb492272 avatar kjb492272 added MBVX
Added to MyStocks 72 days ago
RedDuc avatar RedDuc added MBVX
Added to MyStocks 93 days ago
kks11 avatar kks11 removed MBVX
Removed from MyStocks 107 days ago
kks11 avatar kks11 added MBVX
Added to MyStocks 143 days ago
More MBVX My Stocks Activity


 
 
Board Info
Posts Today
0
Posts (Total)
1194
Posters
248
Moderators
New Post